Advent International to Acquire PatientPoint, the Point of Change
company, elevating healthcare through the nation’s largest
digital point-of-care engagement network
Boston, MA and Cincinnati, OH – August 25, 2025 – Advent
International (“Advent”), a leading global private equity
investor, today announced that it has signed a definitive
agreement to acquire PatientPoint, Inc. (“PatientPoint” or the
“Company”), the nation’s largest digital point-of-care network,
strategically delivering behavior-changing content and measurable
outcomes for patients, providers, and health brands, from an
investor group led by L Catterton and Littlejohn & Co., LLC
(“Littlejohn”). Terms of the transaction were not disclosed.
PatientPoint has more than 35 years of experience transforming
the point-of-care experience by delivering actionable,
educational content, and diagnostic tools to patients and
healthcare providers. Through an interconnected nationwide
network of 30,000 physician offices and 125,000 providers,
PatientPoint delivers measurable outcomes while connecting
patients, providers, and health brands with relevant information
at critical moments of care. PatientPoint’s platform improves
health awareness and drives positive behavior changes while
enabling pharmaceutical and health brand sponsors, health
associations, advocacy groups, and other organizations to reach
highly targeted audiences.
Chris Comenos, Director at Advent, said, “We are thrilled to
partner with PatientPoint, a leader in digital point-of-care
engagement, as it continues its mission of helping patients take
a more active role in understanding and managing their
healthcare. We’re excited to help the Company provide
increasingly targeted messaging about treatment options and
advanced therapies, offering sponsors and partners more
efficient, personalized, and measurable campaigns. Given the
platform’s position in a patient’s healthcare journey, we also
believe it has strong potential to deliver new, innovative
solutions that will drive beneficial health outcomes over time.”
Carmine Petrone, Managing Director at Advent, added, “Drawing on
Advent’s deep experience scaling innovative healthcare and
pharmaceutical services companies, we look forward to working
closely with CEO Sean Slovenski and the PatientPoint team to
accelerate the Company’s network expansion and drive product
innovation through this large and growing channel – delivering
even greater value to providers, partners, and patients
nationwide.”
Sean Slovenski, CEO of PatientPoint, said, “From the beginning,
PatientPoint has been committed to a clear mission: driving
better health outcomes by delivering trusted, behavior-changing
education in the doctor’s office, where decisions are made. With
Advent, we can accelerate growth, expand our network, and
continue to deliver measurable value for providers, patients, and
health brands.
“At PatientPoint, our clients and healthcare providers are at the
heart of everything we do,” said Linda Ruschau, Chief Commercial
Officer of PatientPoint. “This new partnership is an incredible
catalyst for growth. Advent gives us the resources to innovate
faster, expand our reach, and deliver even more value to our
clients as they look to engage audiences at the point of care and
beyond.”
“Our partnership with PatientPoint has been defined by a shared
belief in its mission to transform the point-of-care experience
for patients, providers, and healthcare sponsors,” said Andrew
Taub, a Managing Partner at L Catterton. “We are proud to have
leveraged our deep understanding of consumers to support the
Company’s growth into becoming the clear market leader in patient
engagement and grateful to the team for their vision and
dedication.” “PatientPoint’s growth over the past several years
has been remarkable, and we have been privileged to support the
Company through this important phase of its evolution,” said Drew
Greenwood, Managing Director at Littlejohn. “We look forward to
seeing the Company continue to expand its impact and leadership
in the years ahead.”
PatientPoint will continue to be led by its existing management
team, with support from Advent’s deep bench of advisors with
relevant healthcare and digital expertise.
The transaction is expected to close in the fourth quarter of
2025, subject to customary regulatory approvals and closing
conditions.
About Advent International
Advent is a leading global private equity investor committed to
working in partnership with management teams, entrepreneurs, and
founders to help transform businesses. With 16 offices across
five continents, we oversee more than USD $94 billion in assets
under management* and have made 430 investments across 44
countries.
Since our founding in 1984, we have developed specialist market
expertise across our five core sectors: business & financial
services, consumer, healthcare, industrial, and technology. This
approach is bolstered by our deep sub-sector knowledge, which
informs every aspect of our investment strategy, from sourcing
opportunities to working in partnership with management to
execute value creation plans. We bring hands-on operational
expertise to enhance and accelerate businesses.
As one of the largest privately-owned partnerships, our 660+
colleagues leverage the full ecosystem of Advent’s global
resources, including our Portfolio Support Group, insights
provided by industry expert Operating Partners and Operations
Advisors, as well as bespoke tools to support and guide our
portfolio companies as they seek to achieve their strategic
goals.
About PatientPoint
PatientPoint(r) is the Point of Change company, transforming the
healthcare experience through the strategic delivery of
behavior-changing content at critical moments of care. As the
nation’s largest and most impactful digital network in 30,000
physician offices, we connect patients, providers and health
brands with relevant information that is proven to drive
healthier decisions and better outcomes. Learn more at
patientpoint.com.
About L Catterton
L Catterton is a market-leading consumer-focused investment firm,
managing approximately $37 billion of equity capital across three
multi-product platforms: private equity, credit, and real estate.
The firm’s funds have the ability to invest between $5 million
and $5 billion, across the capital structure, in well-positioned
consumer businesses. Leveraging deep category insight,
operational excellence, and a broad network of strategic
relationships, L Catterton’s team of more than 200 investment and
operating professionals across 18 offices partners with
management teams to drive differentiated value creation across
its portfolio. Founded in 1989, the firm has made over 300
investments in some of the world’s most iconic consumer brands.
For more information about L Catterton, please visit
www.lcatterton.com <http://www.lcatterton.com/> .
About Littlejohn & Co.
Littlejohn & Co. is a Greenwich, Connecticut-based investment
firm focused on private equity and debt investments in growing
middle-market industrial and services companies that can benefit
from Littlejohn’s 25+ years of operational and sector expertise.
With approximately $8 billion in regulatory assets under
management, the firm seeks to build sustainable success for its
portfolio companies through a disciplined approach to engineering
change. For more information about Littlejohn, visit
www.littlejohnllc.com <http://www.lcatterton.com/> .
The M&A market for healthcare companies continues to build on STRATEGIC opportunities and a fragmented market. Consolidations along with unprecedented demand are driving scale across the continuum of care. The strategic corporate buyers and private equity investors remain committed to acquiring strong businesses that are well prepared for a transaction. Across the continuum of care, these buyers and investors are looking for well established, profitable businesses and offering prime valuations and options for management.
Do you know the current market value of your business? We do! We are here to help you plan, prepare, explore and succeed in executing your strategic options.
Contact Paragon Ventures for more information.
800-719-1555
